Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2006
05/17/2006EP1656386A2 A process for preparation of bisphosphonic acid compounds
05/17/2006EP1656385A1 Perfluoropolyether amide-linked phosphonates, phosphates, and derivatives thereof
05/17/2006EP1656357A1 Oxazolidinone antibiotics and derivatives thereof
05/17/2006EP1423398B1 Novel phosphite compounds and novel phosphite metal complexes
05/17/2006EP1418178A4 Flame retardant for polymeric materials
05/17/2006EP1373279B1 Method for producing diphosphines and the use thereof
05/17/2006EP1368360A4 Zwitterionic gemini surfactants for use in carbon dioxide
05/17/2006EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
05/17/2006EP0904275B1 Preparation of phosphorothioate oligomers
05/17/2006CN1774443A Phosphates of secondary alcohols
05/17/2006CN1774442A Phosphate derivatives
05/17/2006CN1774254A Phosphate derivatives of pharmaceutical products
05/17/2006CN1774252A Phospholipid derivatives of valproic acid and mixtures thereof
05/17/2006CN1772756A Prepn process of peonol as active anticancer component
05/16/2006US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies
05/16/2006US7045546 Stabilized derivatives of ascorbic acid-3-phosphate
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006CA2168469C Electron acceptor compositions
05/11/2006WO2006049059A1 Metal compound, thin film-forming material, and method for producing thin film
05/11/2006WO2006049011A1 Method for producing phosphorus compound having phosphate-phosphonate bond
05/11/2006WO2006049010A1 Method for producing phosphonate having alcoholic hydroxy group
05/11/2006WO2006048017A1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
05/11/2006WO2006014282A3 Prodrugs of hiv protease inhibitors
05/11/2006US20060100456 Diastereoselective method of preparing olefins by means of the horner-wadsworthemmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent
05/11/2006US20060100455 Hydrocyanating an unsaturated aliphatic nitrile, or a linear pentenenitrile in a liquid medium with hydrogen cyanide in the presence of a Nickel catalyst with an triaryl phosphite ligand; isomerization
05/11/2006US20060100453 Novel phosoxophite legands and use thereof in carbonylation processes
05/11/2006US20060100433 Organosilicon polymers; light emitting, for electroluminescent devices
05/11/2006US20060100177 Stabilized ascorbic acid derivatives
05/10/2006EP1655990A1 Wireless microphone communication system
05/10/2006EP1655303A2 Hydroxylamine esters as polimerization initiators
05/10/2006EP1655280A1 Dicarboxylic acid derivates with pharmaceutical properties
05/10/2006EP1654292A1 Process for the preparation of a metal-organic compound comprising at least one imine ligand
05/10/2006EP1414832B1 Gold compounds simultaneously coordinated by mono- and bidentate phosphines having antitumoral activity
05/10/2006EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters
05/10/2006EP1062221B1 Process for making glyphosate by oxidizing n-substituted glyphosates
05/10/2006CN1771252A Risedronate sodium having a very low content of iron
05/10/2006CN1771226A 2-propylidene-19-nor-vitamin d compounds
05/10/2006CN1769405A Process for producing zinc dialkyldithiophosphates exhibiting improved seal compatibility properties
05/10/2006CN1255445C Polymer containing phospho-fluoro monomer
05/10/2006CN1255416C Benzoenol phosphonic acid lactone and preparing process thereof
05/10/2006CN1255415C Phosphite ligand and nickel catalyst composition for hydrocyanation of diolefine and isomerization of non-conjugated 2-alkyl-mono-olefinenitrile
05/10/2006CN1255392C Colchinol derivatives as angiogenesis inhibitors
05/09/2006US7041836 Antibiotic compounds
05/09/2006US7041619 allyldiphenyl(sulfophenyl)phosphonium derivative and a palladium compound but comprising no alkali metal compound; reacting a conjugated diene with an active hydrogen compound such as water, an alcohol or a carboxylic acid in the presence of the catalyst; e.g., 2,7-octadien-1-ol from butadiene and water
05/09/2006CA2233666C Heterocyclic fungicides
05/09/2006CA2163336C Ionic conducting material having good anticorrosive properties
05/09/2006CA2116802C Process for the manufacture of poly(hydrocarbylene aryl phosphate) compositions
05/04/2006WO2006047575A2 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
05/04/2006WO2006047545A2 Process for the preparation of highly purified, dialkyl phosphinic acids
05/04/2006WO2006047419A2 Heterobifunctional poly(ethylene glycol) and uses thereof
05/04/2006WO2006046778A1 3-carbamoyl-2-pyridone derivative
05/04/2006WO2006046508A1 Ruthenium complex and process for producing tert-alkyl alcohol therewith
05/04/2006WO2006045597A1 Ligands for use in asymmetric hydroformylation
05/04/2006WO2006045578A2 Process for the preparation of ibandronate
05/04/2006WO2006045546A1 Method of preparing or synthesizing polyazamacrocycle derivatives
05/04/2006WO2006045388A1 Novel bisphosphane catalysts
05/04/2006WO2006045272A1 Method for the production of substituted phosphanes, and substituted phosphanes produced according to said method
05/04/2006WO2006002348A3 Solid and crystalline ibandronic acid
05/04/2006WO2005115150A3 Novel lysophosphatidic acid receptor selective antagonists
05/04/2006WO2005097817A3 Process and reagents for oligonucleotide synthesis and purification
05/04/2006WO2005070901A3 Pyrimidyl phosphonate antiviral compounds and methods of use
05/04/2006US20060094898 Method for synthesizing bisphosphonate
05/04/2006US20060094887 Catalyst useful for various asymmetric synthesis reactions
05/04/2006US20060094877 Process for preparation of benzylpiperidine compounds
05/04/2006US20060094804 Storage stable curable composition
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006US20060092596 Additive for nonaqueous electrolytic solution of electric double layer capacitor and nonaqueous electrolyte electric double layer capacitor
05/04/2006DE102004052725A1 Verfahren zur Herstellung substituierter Phosphane und nach dem Verfahren hergestellte substituierte Phosphane A process for the preparation of substituted phosphines and substituted phosphines prepared by the process
05/04/2006CA2585353A1 Phosphonate derivatives of mycophenolic acid
05/04/2006CA2585125A1 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
05/04/2006CA2584799A1 Amino or thiol linker building block for the synthesis of amino- or thiol-functionalized nucleic acids and methods of making and use thereof
05/04/2006CA2584510A1 Heterobifunctional poly(ethylene glycol) and uses thereof
05/03/2006EP1651737A2 Flame retardant phosphonate additives for thermoplastics
05/03/2006EP1651717A1 Flameproof thermoplastic resin composition
05/03/2006EP1651686A1 Improved method of preparing a hydrocarbylated metal-organic compound
05/03/2006EP1651682A1 Process for the preparation of a metal-organic compound comprising at least one imine ligand
05/03/2006EP1651681A1 Process for the preparation of a metalloorganic compound comprising at least one imine ligand
05/03/2006EP1651678A2 Macrocyclic metal complexes and their uses as polymerization catylysts
05/03/2006EP1651656A1 Process for controlling crystal structure of risedronate
05/03/2006EP1651655A1 A process for the preparation of acylphosphines
05/03/2006EP1651596A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same
05/03/2006EP1412367A4 Novel quinolines and uses thereof
05/03/2006EP1214328B1 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
05/03/2006EP1140951B1 Method for preparing water-soluble sulphonated organophosphorous compounds
05/03/2006EP1102771B1 Preparation of organolithium and organophosphorus derivatives
05/03/2006EP1032837B1 Target sequences for synthetic molecules and methods of using same
05/03/2006EP0934326B1 Substituted aminoalkane phosphonic acids
05/03/2006CN1768070A Asymmetric catalysts prepared from optically active bisphosphites bridged by achiral diols
05/03/2006CN1768069A Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them
05/03/2006CN1768068A Phosphite reactions in the presence of metal soaps for liquid stabilisers
05/03/2006CN1768046A Amine-substituted diphenyldiphosphines and its application in asymmetric synthetic metal complex
05/03/2006CN1765908A Distearopentaerythritoldiphosphite ester synthesis method
05/03/2006CN1765907A Dicetylpentaerythritoldiphosphite ester synthesis method
05/03/2006CN1765906A Preparation method of phosphous dihalide with substituent group
05/03/2006CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
05/02/2006US7038083 Process for making bisphosphonic acids using diluents other than halogenated hydrocarbons
05/02/2006US7038039 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
05/02/2006US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease
05/02/2006US7037642 Removing compounds from blood products with porous particles immobilized in a matrix
05/02/2006US7037486 Labelled phosphoinositides and analogues